David Crottes

Dr. David Crottes

Inserm UMR 1069, Nutrition Croissance Cancer, Faculté de Médecine, Université de Tours, Tours, France
orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 October 2020 in Science Advances
Verified
Journal Article
Open access
PDF file
MLMarco Lolicato
Marco Lolicato
ANAndrew M. Natale
Andrew M. Natale
FAFayal Abderemane-Ali
Fayal Abderemane-Ali
David CrottesDavid Crottes
David Crottes
SCSara Capponi
Sara Capponi
DMDaniel Minor
Daniel Minor
The innately heterodimeric K 2P filter permits two C-type gating mechanisms, pinching and dilation, to operate in one channel.

Verified
Journal Article
Open access
PDF file
MCmathilde cancel
mathilde cancel
WPWilliam Pouillot
William Pouillot
KMKarine Mahéo
Karine Mahéo
AFAlix Fontaine
Alix Fontaine
David CrottesDavid Crottes
David Crottes
GFGaëlle Fromont
Gaëlle Fromont
Adipose tissue is part of the prostate cancer (PCa) microenvironment not only in the periprostatic area, but also in the most frequent metastatic sites, such as bone marrow and pelvic lymph nodes. The involvement of periprostatic adipose tissue (PPAT) in the aggressiveness of PCa is strongly suggested by numerous studies. Many molecules play a role in the reciprocal interaction between adipocytes and PCa cells, including adipokines, hormones, lipids, and also lipophilic pollutants stored in adipocytes. The crosstalk has consequences not only on cancer cell growth and metastatic potential, but also on adipocytes. Although most of the molecules released by PPAT are likely to promote tumor growth and the migration of cancer cells, others, such as the adipokine adiponectin and the n-6 or n-3 polyunsaturated fatty acids (PUFAs), have been shown to have anti-tumor properties. The effects of PPAT on PCa cells might therefore depend on the balance between the pro- and anti-tumor components of PPAT. In addition, genetic and environmental factors involved in the risk and/or aggressiveness of PCa, including obesity and diet, are able to modulate the interactions between PPAT and cancer cells and their consequences on the growth and the metastatic potential of PCa.

1 April 2016 in Cell Calcium
Verified
Journal Article
Closed access
David CrottesDavid Crottes
David Crottes
RFRomain Félix
Romain Félix
DMDaniel Meley
Daniel Meley
SCStéphanie Chadet
Stéphanie Chadet
FHFlorence HERR
Florence HERR
FVFlorence VELGE-ROUSSEL
Florence VELGE-ROUSSEL

18 April 2024 in Journal of Lipid Research
Verified
Journal Article
Open access
MPMarion Papin
Marion Papin
DFDelphine Fontaine
Delphine Fontaine
CGCaroline Goupille
Caroline Goupille
SFSandy Figiel
Sandy Figiel
IDIsabelle Domingo
Isabelle Domingo
CVChristophe Vandier
Christophe Vandier
SK3 channels are potassium channels found to promote tumor aggressiveness. We have previously demonstrated that SK3 is regulated by synthetic ether lipids, but the role of endogenous ether lipids is unknown. Here, we have studied the role of endogenous alkyl- and alkenyl-ether lipids on SK3 channels and on the biology of cancer cells. Experiments revealed that the suppression of alkylglycerone phosphate synthase or plasmanylethanolamine desaturase 1, which are key enzymes for alkyl- and alkenyl-ether-lipid synthesis, respectively, decreased SK3 expression by increasing micro RNA (miR)-499 and miR-208 expression, leading to a decrease in SK3-dependent calcium entry, cell migration, and matrix metalloproteinase 9-dependent cell adhesion and invasion. We identified several ether lipids that promoted SK3 expression and found a differential role of alkyl- and alkenyl-ether lipids on SK3 activity. The expressions of alkylglycerone phosphate synthase, SK3, and miR were associated in clinical samples emphasizing the clinical consistency of our observations. To our knowledge, this is the first report showing that ether lipids differentially control tumor aggressiveness by regulating an ion channel. This insight provides new possibilities for therapeutic interventions, offering clinicians an opportunity to manipulate ion channel dysfunction by adjusting the composition of ether lipids.

19 December 2023 in The Prostate
Verified
Journal Article
Closed access
MCmathilde cancel
mathilde cancel
David CrottesDavid Crottes
David Crottes
DBDorine Bellanger
Dorine Bellanger
FBFrank Bruyère
Frank Bruyère
CMCoralie Mousset
Coralie Mousset
GFGaëlle Fromont
Gaëlle Fromont

2 October 2025 in Cell Communication and Signaling
Verified
Journal Article
Open access
PDF file
ABAmélie E. Bura
Amélie E. Bura
CCCamille Caussette
Camille Caussette
MGMaxime Guéguinou
Maxime Guéguinou
DBDorine Bellanger
Dorine Bellanger
ARAlison Robert
Alison Robert
David CrottesDavid Crottes
David Crottes
Calcium (Ca2+) is an essential second messenger that controls numerous cellular functions. Characteristics of intracellular Ca2+ oscillations define Ca2+ signatures representatives of the phenotype of a cell. Oncogenic functions such as migration, proliferation or resistance to chemotherapy have been associated with aberrant Ca2+ fluxes. However, the identification of Ca2+ signatures representatives of the oncogenic properties of cancer cells remains to be addressed. To characterize and investigate the heterogeneity of oncogenic Ca2+ signatures, we proposed an unbiased scalable method that combines single cell calcium imaging with graph-based unsupervised and artificial neural networks. From an initial dataset of 27,439 agonist-induced Ca2+ responses elicited in a panel of 16 prostate and colorectal cancer cell lines, we discriminate 26 clusters of Ca2+ responses using unbiased unsupervised clustering. From these clusters, we generate Ca2+ signatures for each cancer model allowing to functionally compare different cancer models. In parallel, we propose supervised neural network models predicting characteristics of a single cancer cell based on its profile of Ca2+ responses. We applied those methods to characterized a remodeling of Ca2+ signatures associated with acquired docetaxel resistance (12,911 cells) or in the course of the interaction of cancer cells with fibroblasts (34,676 cells). At single cell level, our supervised neural network succeeded to identify docetaxel-resistant cancer cells and to distinguish cancer cells from fibroblasts on the sole measure of agonist-induced Ca2+ response. Our method demonstrates the potential of Ca2+ profiling for discriminating cancer cells and predict their phenotypic characteristics at single cell level, and provides a framework for researchers to investigate the remodeling of the Ca2+ signature during cancer development.